Skip to content

Clinical trials

Completed Phase 1 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Status: Completed Clear all

796 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200118
200213
200316
200420
200532
200637
200739
200840
200941
201035
201136
201241
201346
201440
201532
201642
201740
201842
201931
202036
202122
202217
202317
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed796

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)54
Novartis Pharmaceuticals23
Memorial Sloan Kettering Cancer Center21
AstraZeneca18
GlaxoSmithKline15
Mayo Clinic14
Washington University School of Medicine13
M.D. Anderson Cancer Center12
Pfizer12
Dana-Farber Cancer Institute11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms796
Ovarian Neoplasms122
Carcinoma, Non-Small-Cell Lung91
Colorectal Neoplasms86
Neoplasms85
Pancreatic Neoplasms85
Prostatic Neoplasms82
Lung Neoplasms78
Stomach Neoplasms69
Melanoma64

Trials

Showing 1 to 25 of 796. Each trial links to its page on Pharma Observatory.

696 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.